A Combination of L‐Triiodothyronine and Levothyroxine in the Treatment of Tyrosine Kinase Inhibitor‐Induced Hypothyroidism in Renal Cell Carcinoma: A Case Report
Hypothyroidism is a common complication in advanced cancer patients taking tyrosine kinase inhibitors. For patients exhibiting suboptimal responses to standard L-T4 therapy, timely consideration of L-T3-containing therapeutic regimens is crucial to prevent the progression of hypothyroidism.
Authors
- Yu‐Bing Wang (ORCID: https://orcid.org/0000-0002-6936-2515)
- Yajuan Han
- Run Miao
- Shuo Chen (ORCID: https://orcid.org/0000-0002-4457-3922)
- Zhao‐Ying Yu
Institutions
- TCM-Intigrated Cancer Center of Southern Medical University (CN)
- Guangzhou Eighth People's Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/ccr3.70955
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Southern Medical University